Clinical Trials Directory

Trials / Unknown

UnknownNCT04834102

COVID-19 Induced Telogen Effluvium

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Istanbul Medeniyet University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection

Detailed description

Telogen effluvium (TE) is one of the most common causes of non-scarring alopecia. During the COVİD-19 pandemic, there is an increased number of Telogen effluvium patients.This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection and correlation between the severity of covid-19 and TE.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood TestsEvaluation of blood ferritin, hemoglobine, serum iron and serum iron binding capacity

Timeline

Start date
2021-01-27
Primary completion
2021-04-27
Completion
2021-04-27
First posted
2021-04-06
Last updated
2021-04-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04834102. Inclusion in this directory is not an endorsement.